0001213900-20-022342.txt : 20200814 0001213900-20-022342.hdr.sgml : 20200814 20200814172147 ACCESSION NUMBER: 0001213900-20-022342 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200812 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Loughlin Steve CENTRAL INDEX KEY: 0001615840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36374 FILM NUMBER: 201106690 MAIL ADDRESS: STREET 1: 955 HARTMAN RUN ROAD CITY: MORGANTOWN STATE: WV ZIP: 26507 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Actinium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001388320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880378336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-677-3875 MAIL ADDRESS: STREET 1: 275 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Cactus Ventures, Inc. DATE OF NAME CHANGE: 20070130 4 1 ownership.xml X0306 4 2020-08-12 0 0001388320 Actinium Pharmaceuticals, Inc. ATNM 0001615840 O'Loughlin Steve C/O ACTINIUM PHARMACEUTICALS, INC. 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 9.55 2020-08-12 4 A 0 59066 0 A 2030-08-12 Common Stock 59066 59066 D This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. /s/ Steve O'Loughlin 2020-08-14